About Sermorelin Field Guide and what it can't answer
Learn what the pages explain, why the name says shop, and when you need your own doctor.
These Sermorelin pages explain studies, not your care
The drug Sermorelin asks a small gland under your brain to send out growth hormone. This page explains what the guide can tell you. Editors read published medical work and put each finding into everyday words. A number beside a claim identifies its study.
No clinic operates here, and the editors aren't your doctors. The pages can't tell you what illness you have or how to treat it. Nothing is made, stocked, sold, or sent from here. The word "shop" in the name doesn't make this guide a store.
You can use the studies to prepare questions. Your own health questions need a licensed doctor who knows your full record.
The word shop doesn't mean you can buy Sermorelin here
The web address includes the word "shop." That word doesn't mean Sermorelin is sold here. You won't see prices, order forms, seller lists, or links for buying medicine.
This guide can't help a buyer. It can help a reader understand what a study found. The name belongs to a reading guide, not a store.
You are reading about medical work. You aren't at a checkout.
The approved Sermorelin drug left the market for business reasons
The approved medicine was Sermorelin acetate. Acetate means the drug was prepared as a salt; it wasn't a different active medicine. Doctors used it for children whose bodies made too little growth hormone. Business reasons led the brand to leave the U.S. market in 2008. The withdrawal wasn't caused by proof of harm or failure [1][5]. The old brand stopped being sold, but the drug wasn't banned.
Some pharmacies may now make Sermorelin for one patient at a time. The FDA page tied to final guidance dated January 2025 says the agency doesn't plan to act against this pharmacy work while it reviews the drug ingredient. The agency calls it a Category 1 ingredient. That temporary review label doesn't mean FDA approved the pharmacy-made drug.
The policy doesn't approve Sermorelin for aging or general well-being. It also doesn't cover every drug that affects growth hormone.
What these limits mean when you read a claim
A claim's number leads to its study in the reference list. That lets you see which people were studied and what happened. The pages describe what researchers gave their groups, but they don't turn those amounts into advice for you.
Adult use against aging still lacks strong, long studies. When proof is weak, the answer stays uncertain. A hopeful short study can't fill that long-term gap.
You get the finding, the doubt that comes with it, and the paper behind it.